MO vs VRTX · P/E 14, rev $23.28B vs P/E 30, rev $12.00B
Altria Group (MO) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Altria Group (MO) is a tobacco company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported MO revenue for 2025-12-31 was $23.28B. Net income was $6.95B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. MO currently screens at market cap $115.14B and trailing P/E 14.4.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
MO currently screens at market cap $115.14B and trailing P/E 14.4. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the MO and VRTX stock pages for the full models.
Not investment advice.